Hendrik W. van Deventer

1.1k total citations
25 papers, 567 citations indexed

About

Hendrik W. van Deventer is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Hendrik W. van Deventer has authored 25 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Hendrik W. van Deventer's work include Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Hendrik W. van Deventer is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). Hendrik W. van Deventer collaborates with scholars based in United States, Italy and Germany. Hendrik W. van Deventer's co-authors include Jonathan S. Serody, Qing Wu, W. June Brickey, Jenny P.‐Y. Ting, Jenny P.‐Y. Ting, E.C. McCook, Irving C. Allen, Rita-Marie T. Woodford, Joseph E. Burgents and Erin McElvania and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Hendrik W. van Deventer

24 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hendrik W. van Deventer United States 12 272 239 224 88 62 25 567
Melanie Märklin Germany 13 364 1.3× 295 1.2× 229 1.0× 100 1.1× 66 1.1× 49 686
Arnika Kathleen Wagner Sweden 13 337 1.2× 236 1.0× 239 1.1× 122 1.4× 62 1.0× 43 688
Qianshan Tao China 16 362 1.3× 310 1.3× 156 0.7× 161 1.8× 39 0.6× 58 641
R. Handgretinger Germany 15 226 0.8× 222 0.9× 228 1.0× 109 1.2× 75 1.2× 33 718
Seiji Nagano Japan 12 232 0.9× 335 1.4× 277 1.2× 58 0.7× 26 0.4× 25 607
Sunil S. Raikar United States 13 252 0.9× 405 1.7× 205 0.9× 108 1.2× 34 0.5× 37 639
Haizhou Xing China 11 180 0.7× 208 0.9× 192 0.9× 162 1.8× 81 1.3× 31 561
Martín Bonamino Brazil 12 171 0.6× 233 1.0× 139 0.6× 100 1.1× 27 0.4× 27 460
Michael Shepard United States 7 259 1.0× 380 1.6× 238 1.1× 105 1.2× 46 0.7× 13 747
Adam Asch United States 8 371 1.4× 83 0.3× 171 0.8× 118 1.3× 54 0.9× 27 689

Countries citing papers authored by Hendrik W. van Deventer

Since Specialization
Citations

This map shows the geographic impact of Hendrik W. van Deventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik W. van Deventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik W. van Deventer more than expected).

Fields of papers citing papers by Hendrik W. van Deventer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik W. van Deventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik W. van Deventer. The network helps show where Hendrik W. van Deventer may publish in the future.

Co-authorship network of co-authors of Hendrik W. van Deventer

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik W. van Deventer. A scholar is included among the top collaborators of Hendrik W. van Deventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik W. van Deventer. Hendrik W. van Deventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vincent, Benjamin G., Karen P. McKinnon, Jeffrey A. Frelinger, et al.. (2023). Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors. The Journal of Immunology. 211(2). 219–228. 11 indexed citations
2.
Kumar, Vaibhav, Nathan D. Montgomery, Hendrik W. van Deventer, & Young E. Whang. (2023). Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report. Journal of Medical Case Reports. 17(1). 220–220. 1 indexed citations
3.
Woods, Justin, Joshua F. Zeidner, Hendrik W. van Deventer, et al.. (2021). Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains. Journal of Geriatric Oncology. 13(4). 499–504. 2 indexed citations
4.
5.
Muluneh, Benyam, Allison M. Deal, Joshua F. Zeidner, et al.. (2017). A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML. Clinical Lymphoma Myeloma & Leukemia. 18(1). e13–e18. 9 indexed citations
6.
Deventer, Hendrik W. van, Stuart Gold, Katarzyna Jamieson, et al.. (2015). A Single-Center Retrospective Analysis of a Pediatric Salvage Chemotherapy Regimen for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood. 126(23). 4919–4919.
7.
8.
Deventer, Hendrik W. van, Daniela Palmieri, Qing Wu, E.C. McCook, & Jonathan S. Serody. (2013). Circulating Fibrocytes Prepare the Lung for Cancer Metastasis by Recruiting Ly-6C+ Monocytes Via CCL2. The Journal of Immunology. 190(9). 4861–4867. 74 indexed citations
9.
Buckner, Tyler W., Cherie H. Dunphy, Yuri Fedoriw, et al.. (2012). Complete Spontaneous Remission of Diffuse Large B-Cell Lymphoma of the Maxillary Sinus After Concurrent Infections. Clinical Lymphoma Myeloma & Leukemia. 12(6). 455–458. 28 indexed citations
10.
Foster, Matthew C., Chirag Amin, Peter M. Voorhees, et al.. (2011). A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia. Leukemia & lymphoma. 53(7). 1331–1337. 11 indexed citations
11.
12.
Deventer, Hendrik W. van, Joseph E. Burgents, Qing Wu, et al.. (2010). The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells. Cancer Research. 70(24). 10161–10169. 135 indexed citations
13.
Amin, Chirag, Peter M. Voorhees, Hendrik W. van Deventer, et al.. (2009). A Phase I, Dose Escalation Study of Clofarabine in Combination with Fractionated Gemtuzumab Ozogamicin in Relapsed and Refractory Acute Myeloid Leukemia (AML).. Blood. 114(22). 2048–2048. 1 indexed citations
14.
Deventer, Hendrik W. van, et al.. (2009). Pulmonary Stromal Cells Expressing CC-Chemokine Receptor 5 Promote Metastasis Via Erythroid Differentiation Regulator 1.. Blood. 114(22). 3601–3601. 1 indexed citations
15.
Deventer, Hendrik W. van, Qing Wu, Dan T. Bergstralh, et al.. (2008). C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9. American Journal Of Pathology. 173(1). 253–264. 48 indexed citations
16.
Iocca, Heather A., Sheila R. Plant, Ying Wang, et al.. (2008). TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. Journal of Neuroimmunology. 194(1-2). 97–106. 26 indexed citations
17.
Moore, Chris B., Miguel Á. Medina, Hendrik W. van Deventer, et al.. (2007). Downregulation of Immune Signaling Genes in Patients With Large Surface Burn Injury. Journal of Burn Care & Research. 28(6). 879–887. 15 indexed citations
18.
Deventer, Hendrik W. van, William O’Connor, W. June Brickey, et al.. (2005). C-C Chemokine Receptor 5 on Stromal Cells Promotes Pulmonary Metastasis. Cancer Research. 65(8). 3374–3379. 40 indexed citations
19.
Deventer, Hendrik W. van, Robert Z. Orlowski, Beverly S. Mitchell, et al.. (2002). Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemia. American Journal of Hematology. 71(3). 184–190. 9 indexed citations
20.
Deventer, Hendrik W. van, Jonathan S. Serody, Karen P. McKinnon, et al.. (2002). Transfection of Macrophage Inflammatory Protein 1α into B16 F10 Melanoma Cells Inhibits Growth of Pulmonary Metastases But Not Subcutaneous Tumors. The Journal of Immunology. 169(3). 1634–1639. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Märklin Breakdown of academic impact, for papers by Arnika Kathleen Wagner Breakdown of academic impact, for papers by Qianshan Tao Breakdown of academic impact, for papers by R. Handgretinger Breakdown of academic impact, for papers by Seiji Nagano Breakdown of academic impact, for papers by Sunil S. Raikar Breakdown of academic impact, for papers by Haizhou Xing Breakdown of academic impact, for papers by Martín Bonamino Breakdown of academic impact, for papers by Michael Shepard Breakdown of academic impact, for papers by Adam Asch
Rankless by CCL
2026